Ligand Pharmaceuticals (LGND) SG&A Expense (TTM): 147.60M | YCharts

Ligand Pharmaceuticals, Inc. (LGND)

299.00 -17.13 (-5.42%) USD | NASDAQ | Nov 05, 16:00

298.00 -1.00 (-0.33%) After-Hours: 20:00

SG&A Expense (TTM) Chart

Historical SG&A Expense (TTM) Data

View and export this data back to 1998. Start Trial.

Date	Value
September 30, 2026	147.60M
June 30, 2026	103.43M
March 31, 2026	94.48M
December 31, 2025	92.45M
September 30, 2025	93.03M
June 30, 2025	89.06M
March 31, 2025	86.50M
December 31, 2024	78.65M
September 30, 2024	69.04M
June 30, 2024	59.22M
March 31, 2024	52.89M
December 31, 2023	52.79M
September 30, 2023	67.93M
June 30, 2023	68.19M
March 31, 2023	68.99M
December 31, 2022	70.06M
September 30, 2022	51.53M
June 30, 2022	49.32M
March 31, 2022	51.95M
December 31, 2021	52.64M
September 30, 2021	70.13M
June 30, 2021	72.43M
March 31, 2021	67.79M
December 31, 2020	64.44M
September 30, 2020	44.63M

Date	Value
June 30, 2020	39.14M
March 31, 2020	40.06M
December 31, 2019	41.88M
September 30, 2019	42.77M
June 30, 2019	42.88M
March 31, 2019	41.18M
December 31, 2018	37.73M
September 30, 2018	34.32M
June 30, 2018	31.72M
March 31, 2018	28.97M
December 31, 2017	28.65M
September 30, 2017	27.53M
June 30, 2017	26.80M
March 31, 2017	27.12M
December 31, 2016	26.62M
September 30, 2016	26.18M
June 30, 2016	24.85M
March 31, 2016	25.21M
December 31, 2015	24.38M
September 30, 2015	23.79M
June 30, 2015	25.56M
March 31, 2015	23.57M
December 31, 2014	22.65M
September 30, 2014	21.47M
June 30, 2014	19.49M

SG&A Expense (TTM) Range, Past 5 Years

View SG&A Expense (TTM) Range, Past 5 Years

Start Trial

--

Minimum

--

Maximum

--

Average

--

Median

SG&A Expense (TTM) Benchmarks

View SG&A Expense (TTM) Benchmarks

Start Trial

Johnson & Johnson	25.50B
Eli Lilly & Co.	12.62B
Merck & Co., Inc.	11.39B
Indivior Pharmaceuticals, Inc. (DELISTED)	555.00M
Bristol Myers Squibb Co.	7.323B